|
US2016153037A1
|
|
Methods to detect a silent carrier of a null allele genotype
|
|
CA2928030A1
|
|
Pathogenicity scoring system for human clinical genetics
|
|
WO2014197805A2
|
|
Molecular barcoding for multiplex sequencing
|
|
CA2658421A1
|
|
Pkd mutations and evaluation of same
|
|
US2007190555A1
|
|
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
|
|
CA2461106A1
|
|
Compositions and methods for genetic analysis of polycystic kidney disease
|
|
US2005100898A1
|
|
Compositions and methods for genetic analysis of polycystic kidney disease
|
|
US2003152936A1
|
|
Compositions and methods for genetic analysis of polycystic kidney disease
|
|
US6599756B1
|
|
Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
|
|
US6824999B1
|
|
Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
|
|
US6001576A
|
|
Mutations relating to X-linked charcot-marie-tooth disease
|
|
US5691144A
|
|
Methods of detecting novel mutations relating to X-linked Charcot-Marie-Tooth disease
|
